drugset / Trial / NCT00852241

Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study

NCT00852241

Phase 4 Completed 18 enrolled The Cleveland Clinic
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment

Timeline

Start
2009-02
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIC ACID (NON-ANIMAL STABILIZED) Unknown 1 ml
Subject Restalyne Unknown 1 ml

Indications

No indication recorded.